A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
Clinical trial NCT06122831 · RECRUITING
Trial details
- NCT number
- NCT06122831
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-12
- Primary completion
- 2026-12-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.